The branded product, prescribed properly.
Wegovy is dispensed as the manufacturer supplies it, on a prescription written after a clinician review. Whether it is appropriate for you is a decision for your clinician.
What is it
Wegovy is semaglutide manufactured by Novo Nordisk and approved by the FDA for chronic weight management in adults who meet defined criteria. It is dispensed by a licensed U.S. pharmacy on a prescription written after a clinician review.
Compare all semaglutide options →How it works in the body
Acts on GLP-1 receptors
Semaglutide binds the receptors the body’s own GLP-1 hormone acts on, including sites involved in appetite regulation.
Slows gastric emptying
It slows the rate at which the stomach empties, which is part of how the GLP-1 pathway signals fullness.
Prescribed and reviewed
Dosing is set by your clinician, started low, and reviewed over time for as long as you are treated.
Switching
Yes. You can transfer from another provider and continue on the same or an equivalent dose. This is confirmed during your medical intake so the clinician can prescribe the right dose for you.
Pricing
Transparent pricing — no membership, no hidden fees. Billed on the schedule you choose; cancel before your next renewal. Prescriptions require clinician approval; if you are not approved, you are not charged.
Start your consultationDisclosures
This treatment is provided through a subscription that renews at the interval you select unless cancelled before the next renewal date. Cancellation & refund details.
Wegovy® is a registered trademark of Novo Nordisk A/S. Tomorrow is not affiliated with, endorsed by, or sponsored by Novo Nordisk. Refer to the manufacturer’s prescribing information supplied with your medication.
Sourcing
Manufactured by Novo Nordisk and dispensed by a licensed U.S. pharmacy. This is the branded product, not a compounded preparation.
Dosing
Wegovy® is injected once weekly, on the same day each week. The approved schedule is 0.25 mg for weeks 1–4, 0.5 mg for weeks 5–8, 1 mg for weeks 9–12, and 1.7 mg for weeks 13–16, then a maintenance dose of 2.4 mg or 1.7 mg once weekly. A 7.2 mg dose (Wegovy® HD) is also approved for some adults who have tolerated 2.4 mg for at least 4 weeks, at their clinician’s discretion. Your clinician may slow increases if side effects occur. Informational only; follow your prescription and the manufacturer’s Instructions for Use.
How it works
- 01 Complete a medical intake for clinician review.
- 02 A licensed clinician reviews your history and decides if it’s appropriate.
- 03 If approved, your prescription ships to your door.
Important safety information
Wegovy® carries a boxed warning about possible thyroid tumors. Do not use it if you or a family member have had medullary thyroid carcinoma (MTC) or if you have MEN 2. Serious risks include pancreatitis, gallbladder problems, and severe allergic reactions.
Read the full important safety information →Related
RxA GLP-1 receptor agonist, compounded and prescribed for you.
- Injection supplies included
- Clinician review and ongoing oversight
- Shipping included
RxTirzepatide, manufactured by Eli Lilly.
- FDA-approved, brand-name pen
- Made by Eli Lilly
- Prescribed after clinician review
Common questions
Care that keeps showing up.
Check-ins as you go
Your plan is revisited as your body and goals change, not set once and forgotten.
Ships in about two days
Once you’re prescribed, your order typically ships within two business days, discreetly.
You control renewals
Choose whether your plan renews automatically, and cancel anytime from your account.
No membership, no surprises
No insurance or membership needed. You see the price before you decide.